Tobramycin

ArticlesRefrigerated StorageLactation Safety Information ·
89695009

Articles

Refrigerated Storage

TobiMylan

Mylan
Tobi
Nebuliser solution 300mg/5ml

In the event of an inadvertent temperature excursion the following data may be used:
After removal from the refrigerator, or if refrigeration is unavailable, TOBI pouches (intact or opened) may be stored at up to 25°C for up to 28 days.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk.

Contact Mylan in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Yes. If exposed to temperatures of up to 25°C, reduce the expiry date to 28 days from date of excursion.
No.
14 May 2020
London MI Service

BramitobChiesi

Chiesi
Bramitob
300 mg/4ml Nebuliser Solution

In the event of an inadvertent temperature excursion the following data may be used:
After first opening the single-dose container: use immediately.
In use shelf life: Bramitob bags (intact or opened) may be stored for up to 3 months at not more than 25°C by the end user
Prior to dispensing: Contact Chiesi in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Yes
22 May 2019
London MI services

VantobraPARI Pharma GmbH 

PARI Pharma GmbH 
Vantobra
Nebuliser solution

The manufacturer does not hold stability data in addition to that provided in the Summary of Product Characteristics (SPC).

Please refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

5 August 2020
London MI Service

Lactation Safety Information

Parenteral / Inhalation

Parenteral / Inhalation
Gentamicin for parenteral use.
No aminoglycoside alternative for inhalation use
Limited published evidence of safety for parenteral use and no published evidence regarding administration via inhalation, although not considered to pose an increased risk
Small amounts in breast milk
Minimal absorption from the infant's GI tract
11 September 2020

For ophthalmic use

For ophthalmic use
11 September 2020